Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Angibloc 25mg Tablet ER

Prescription Icon
Prescription Required

Marketer

Alkem Laboratories Ltd

Salt Composition

Metoprolol Succinate (25mg)

Overview Angibloc 25mg Tablet ER

CardioGuard 25mg Extended-Release Tablets are a beta-blocker medication indicated for hypertension management, angina pectoris relief, and the treatment of cardiac arrhythmias. This medication also contributes to migraine prophylaxis and reduces the risk of future myocardial infarction and cerebrovascular events. CardioGuard 25mg ER may be administered alone or in conjunction with other therapies, with dosage and frequency tailored to individual needs and condition severity. It can be taken with or without food, but consistent daily timing is crucial for optimal efficacy. Full therapeutic benefit may take several weeks to manifest, and long-term use is often necessary. Discontinuing treatment, even if feeling well, can exacerbate underlying conditions. Common side effects, typically mild and transient, include fatigue, cephalalgia, depressive symptoms, diarrhea, skin rash, bradycardia, dizziness, and nausea. Less frequent side effects include dyspnea and hypotension. To minimize adverse effects, a gradual dose escalation is typically employed. Report persistent or bothersome side effects to your physician. Prior to initiating therapy, inform your doctor of any hepatic impairment. This medication may be contraindicated in patients with bradycardia, severe peripheral vascular disease, decompensated heart failure, or hypotension. Pregnant or lactating individuals should seek medical counsel before use. Individual suitability should be determined by a healthcare professional, and regular blood pressure monitoring is essential to assess treatment efficacy. Alcohol consumption should be limited due to the potential for increased side effect occurrence.

Uses of Angibloc 25mg Tablet ER

Managing angina pectoris (chest pain due to heart issues)|Correcting cardiac arrhythmias|Avert myocardial infarction|Controlling hypertension (elevated blood pressure)|Prophylaxis against migraine headaches

Major Benefits of Angibloc 25mg Tablet ER:

Administer Angibloc 25mg Extended-Release Tablets precisely as directed by your physician. The tablets should be swallowed whole; do not crush, chew, or divide them. While this medication may be ingested with or without food, consistent timing is recommended. For optimal absorption, it's advisable to avoid consuming Angibloc 25mg ER with meals high in fat, including those containing olive oil, nuts and seeds (like Brazil nuts), dark chocolate, butter, and red meat.

Common Side effects of Angibloc 25mg Tablet ER:

  • Tiredness
  • Dizziness
  • Depression
  • Breathlessness
  • Headache
  • Slow heart rate
  • Nausea
  • Rash
  • Diarrhea
  • Hypotension (low blood pressure)

How to use Angibloc 25mg Tablet ER:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid crushing, chewing, or breaking it. Angibloc 25mg Extended-Release Tablets can be taken with or without food, though consistent timing is recommended. To optimize efficacy, limit consumption of Angibloc 25mg ER tablets with meals high in fat, including items like olive oil, nuts (especially Brazil nuts), dark chocolate, butter, and fatty meats.

How Angibloc 25mg Tablet ER works:

CardioBloc 25mg Extended-Release tablets are a sustained-action beta-adrenergic blocker targeting cardiac function. This medication reduces heart rate and enhances the heart's circulatory efficiency.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Angibloc 25mg Extended-Release Tablets with alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Angibloc 25mg tablets might pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Extended-release Angibloc 25mg tablets are likely safe for breastfeeding mothers. Available human data indicate minimal risk to the infant.

DrivingDrivingUNSAFE

Extended-release Angibloc 25mg tablets can cause drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects are experienced.

KidneyKidneySAFE IF PRESCRIBED

Extended-release Angibloc 25mg tablets are considered safe for individuals with kidney impairment. No alteration of the Angibloc 25mg extended-release tablet dosage is necessary.

LiverLiverCAUTION

Extended-release Angibloc 25mg tablets require careful administration for individuals with hepatic impairment. Dosage modification of Angibloc 25mg extended-release tablets may be necessary. Physician consultation is advised.

What if you forget to take Angibloc 25mg Tablet ER :

Should you forget a dose of Angibloc 25mg Extended-Release Tablet, take it immediately if remembered. However, near the time for your next dose, omit the missed dose and resume your usual dosing pattern. Never take a double dose.

Facts to Know About Angibloc 25mg Tablet ER

LabelValue
Type of Compound Ethyl alcohol and phenolic compounds
Addictive None.
Medication Category HEART

FAQs on Angibloc 25mg Tablet ER

Individual responses to Angibloc 25mg Extended-Release tablets vary. Onset typically occurs within 15 minutes, although a response may take up to two hours in some cases. The therapeutic effect develops gradually, with maximal benefit generally observed after one week of consistent use. Lack of immediate noticeable improvement with Angibloc 25mg ER is not cause for alarm; sustained use is necessary to achieve its full therapeutic potential.
Extended-release Angibloc 25mg tablets are generally well-tolerated when administered according to a physician's instructions. Discontinuing this medication abruptly poses significant risks. Sudden cessation can trigger a rapid increase in heart rate and disrupt cardiac function, potentially causing serious complications for individuals with heart failure, including the possibility of myocardial infarction. Therefore, it is crucial to avoid abrupt discontinuation and to adhere to the prescribed treatment regimen.
Extended-release Angibloc 25mg tablets are classified as beta-blockers. While individual responses differ, these medications can sometimes modify sleep patterns and cause sleep disruption in some users. Conversely, they may improve sleep quality in individuals experiencing elevated heart rate and anxiety by reducing cardiovascular and nervous system activity. Consult your physician regarding any sleep-related issues.
Refrain from alcohol consumption following ingestion of Angibloc 25mg Extended-Release tablets. Alcohol can potentiate this medication's hypotensive action, resulting in dangerously low blood pressure.
Angibloc 25mg Tablet ER
30
MRP 35
13% off